Advanced magnetic visualization of Mt. Vesuvius shallow plumbing system by probability tomography

We show the results of the application of a new magnetic probability tomography imaging method to the aeromagnetic dataset collected by AGIP on Mt. Vesuvius in 1978. A magnetic dipole occurrence probability function is defined in such a way as to contain all information about the whole class of equivalent sources compatible with the original survey dataset. An advanced 3D visual system is also applied for the first time to visualise the spacial pattern of the magnetic dipole occurrence probability function. It is shown that in the case of Vesuvius, the shallow plumbing system is characterised by a high probability of occurrence of a dipole at 2 km of depth b.s.l., nearly directed along the present main earth’s magnetic field. This leads to hypothesize that the top terminal portion of the volcanic apparatus is completely filled with magnetised volcanic material

Aspectos ultra-sonográgicos da cavidade abdominal de ferrets

O artigo não apresenta resumo

Orbital solitary fibrous tumors: A multi-centered histopathological and immunohistochemical analysis with radiological description

BACKGROUND: Solitary fibrous tumors (SFT), formerly called hemangiopericytoma, are rare tumors derived from mesenchymal cells originally described in the pleura, but these tumors may affect extraserosal tissues including the lacrimal gland and orbit. OBJECTIVE: Conduct a multi-centered clinical, radiological and histopathological analysis of 17 orbital SFT cases. DESIGN: A retrospective case series. SETTING: Three eye centers in two countries. PATIENTS AND METHODS: The data collected from the charts of 17 adult patients presenting with tissue diagnosis of orbital hemangiopericytoma or SFT from January 2003 to December 2018 included demographics, clinical imaging and histopathological information including immunohistochemical (IHC) characteristics. MAIN OUTCOME MEASURES: The demographic characteristics, clinical presentation, and histopathological patterns or variants of SFT were analyzed. SAMPLE SIZE: 17 adult patients. RESULTS: Mean age was 45 years (range 23-80 years). Male to female ratio was 3:1. The right eye was affected in 12 (70.5%) patients. Commonest presentation was proptosis in 13/17 (76% of patients). Other symptoms were impaired motility (29%) and ptosis (11%). Lesions mostly affected the medial orbit (35%), then orbital apex in 11%. The histopathological classic pattern-less variant was the commonest. One case with aggressive behavior, multiple recurrences and atypical features was encountered. Immunohistochemical (IHC) markers used included CD34 expression in all cases, Bcl-2 expression in 10/11, CD99 in 9/9 and Vimentin in 4/4. STAT6 was used in 2 cases. CONCLUSIONS: SFTs are rare tumors affecting the orbit in both genders equally in their mid-forties, but showed male predominance in our analysis with a predominant classic histopathological pattern. Tissue diagnosis is essential and requires IHC studies for confirmation. LIMITATIONS: Sample size is relatively small owing to the rarity of this tumor in the orbit. CONFLICT OF INTEREST: None

Sistema informático para el proceso de referencia-contrarreferencia de pacientes

La incesante y creciente demanda de la población por una buena atención médica ha hecho de la referencia y contra-referencia de pacientes, un procedimiento administrativo asistencial de significativa importancia. Tal proceso comienza con una referencia o derivación de un paciente desde un establecimiento de menor capacidad resolutiva hacia otro de mayor complejidad en la asistencia, complementación diagnóstica o terapéutica, y finaliza con una contra-referencia o traslado del paciente al establecimiento del que provino, acompañado de un diagnóstico concreto, información sobre los servicios prestados y respuestas e indicaciones a las solicitudes de apoyo asistencial. Este artículo presenta un sistema informático desarrollado con tecnologías Free/Libre Open Source Software (FLOSS) [1] para promover la utilización adecuada y eficiente del Hospital Especializado “Dr. Noel H. Sbarra” [2], mejorar la interacción entre los profesionales pertenecientes a la “red” de salud descripta, de manera de aumentar la capacidad resolutiva del primer nivel de atención y evitar derivaciones innecesarias de niños y jóvenes. Cabe destacar que la implementación del sistema informático ha estado a cargo de alumnos de una cátedra perteneciente al último año de una de las carreras de grado de la Facultad de Informática de la Universidad Nacional de La Plata [3].Sociedad Argentina de Informática e Investigación Operativ

P14 282. Endocarditis protésica. experiencia de 20 años

ObjetivosRevisamos la experiencia de nuestro centro en endocarditis protésica (EP).Material y métodosEntre 1990–2010, se intervienen 62 casos, que representaron el 23% de 276 casos totales de endocarditis y 2,46% de pacientes valvulares (precoces 0,58% con 20 casos, tardías 1,68% con 42 casos). No hubo diferencias en tipo ni localización de las prótesis, ni en incidencia entre las dos décadas (2,59% en 1990–2000 y 2,32% en 2000–2010). Edad media 59 años. Gérmenes: S. viridans 20,9%; S. epidermidis 16,1%; S. aureus 11,6%; C. burnetii 9,6%; enterococos 8%; difteroides 6,4%; hongos 6,4%. En un 8% de los casos se encontraron gérmenes raros aislados, mientras que no se identificó germen en 12,9%. Se intervinieron de forma urgente el 30% de pacientes (19 casos, el 45% de formas precoces y el 23% de formas tardías).ResultadosLa mortalidad precoz fue del 16%, a expensas sobre todo de EP precoz (12%). La supervivencia global a 10 años fue del 50%, con diferencias entre los dos grupos (EP precoz 15%; EP tardía 66%). El 70% de supervivientes se encuentra actualmente en clase funcional I-II/IV.ConclusiónLa EP sigue teniendo una incidencia relativamente elevada en nuestro medio. La EP precoz tiene una mortalidad muy elevada. La cirugía de la EP tardía tiene muy buenos resultados a largo plazo

Community perceptions matter: a mixed-methods study using local knowledge to define features of success for a community intervention to improve quality of care for children under-5 in Jigawa, Nigeria

Objectives In this study, we used the information generated by community members during an intervention design process to understand the features needed for a successful community participatory intervention to improve child health. Design We conducted a concurrent mixed-methods study (November 2019–March 2020) to inform the design and evaluation of a community–facility linkage participatory intervention. Setting Kiyawa Local Government Area (Jigawa State, Nigeria)—population of 230 000 (n=425 villages). Participants Qualitative data included 12 community conversations with caregivers of children under-5 (men, older and younger women; n=9 per group), 3 focus group discussions (n=10) with ward development committee members and interviews with facility heads (n=3). Quantitative data comprised household surveys (n=3464) with compound heads (n=1803) and women (n=1661). Results We analysed qualitative data with thematic network analysis and the surveys with linear regression—results were triangulated in the interpretation phase. Participants identified the following areas of focus: community health education; facility infrastructure, equipment and staff improvements; raising funds to make these changes. Community involvement, cooperation and empowerment were recognised as a strategy to improve child health, and the presence of intermediate bodies (development committees) was deemed important to improve communication and solve problems between community and facility members. The survey showed functional community relations’ dynamics, with high levels of internal cohesion (78%), efficacy in solving problems together (79%) and fairness of the local leaders (82%). Conclusions Combining the results from this study and critical theories on successful participation identified community-informed features for a contextually tailored community–facility link intervention. The need to promote a more inclusive approach to future child health interventions was highlighted. In addition to health education campaigns, the relationship between community and healthcare providers needs strengthening, and development committees were identified as an essential feature for successfully linking communities and facilities for child health. Trial registration number ISRCTN39213655

Myositis/myasthenia after pembrolizumab in a bladder cancer patient with an autoimmunity-associated HLA: Immune\u2013biological evaluation and case report

Pembrolizumab (mAb to PD-1) has been recently approved for the therapy of pretreated urothelial cancer. Despite the efficacy, it is often accompanied by unpredictable and sometime severe immune-related (ir) adverse events (AEs). Here, we report the clinical and immune\u2013biological characterization of a patient with a metastatic bladder cancer who developed myositis signs (M) and a myasthenia-like syndrome (MLS) during treatment with pembrolizumab. The patient presented an autoimmunity-associated HLA haplotype (HLA-A*02/HLA-B*08/HLA-C*07/HLA-DRB1*03) and experienced an increase in activated CD8 T-cells along the treatment. The symptomatology regressed after pembrolizumab discontinuation and a pyridostigmine and steroids-based therapy. This is the first report of concurrent M and MLS appearance in cancer patients receiving pembrolizumab. More efforts are needed to define early the risk and the clinical meaning of irAEs in this setting

SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation

Background/Aims: Published observations on serum and glucocorticoid regulated kinase 1 (Sgk1) knockout murine models and Sgk1-specific RNA silencing in the RKO human colon carcinoma cell line point to this kinase as a central player in colon carcinogenesis and in resistance to taxanes. Methods: By in vitro kinase activity inhibition assays, cell cycle and viability analysis in human cancer model systems, we describe the biologic effects of a recently identified kinase inhibitor, SI113, characterized by a substituted pyrazolo[3,4-d]pyrimidine scaffold, that shows specificity for Sgk1. Results: SI113 was able to inhibit in vitro cell growth in cancer cells derived from tumors with different origins. In RKO cells, this kinase inhibitor blocked insulin-dependent phosphorylation of the Sgk1 substrate Mdm2, the main regulator of p53 protein stability, and induced necrosis and apoptosis when used as a single agent. Finally, SI113 potentiated the effects of paclitaxel on cell viability. Conclusion: Since SI113 appears to be effective in inducing cell death in RKO cells, potentiating paclitaxel sensitivity, we believe that this new molecule could be efficiently employed, alone or in combination with paclitaxel, in colon cancer chemotherapy